E-cadherin and gastric cancer: cause, consequence, and applications
about
Molecular mechanisms of peritoneal dissemination in gastric cancerEmerging molecular basis of hematogenous metastasis in gastric cancerUnraveling the Anticancer Effect of Curcumin and ResveratrolAberrant methylation patterns in cancer: a clinical view.The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.Systematic chromatin state comparison of epigenomes associated with diverse properties including sex and tissue type.Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.Clinical relevance of breast and gastric cancer-associated polymorphisms as potential susceptibility markers for oral clefts in the Brazilian populationProphylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer.Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guidelineDownregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy.Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer.Expression and potential roles of sodium-potassium ATPase and E-cadherin in human gastric adenocarcinomaGene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.Influence of the Twist gene on the invasion and metastasis of colon cancer.Oncogenic KRAS and p53 Loss Drive Gastric Tumorigenesis in Mice That Can Be Attenuated by E-Cadherin Expression.Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients.Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer.An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer.MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma.Diffuse Gastric Carcinoma Undergoes Characteristic Phenotypic Changes in the Intravascular Environment: Evidence for a Reversal of the Epithelial-Mesenchymal Transition in Lymphovascular Metastasis.Association Between IL-4 and IL-6 Expression Variants and Gastric Cancer Among Portuguese Population.Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal TransitionDiffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity
P2860
Q26738538-F2BE3130-2036-4702-8547-531E2C4B24E8Q26764924-DFAE17EE-89C9-4F76-9C29-C0F63FBB5F4FQ28073155-BCC87157-1567-466F-8BF0-CD27C6D9CC9BQ35750355-40531CB7-EF15-46A1-BB8A-4CB4F45D68CAQ35986338-81F6281F-418A-4AD3-84F8-3B1F7EA5C368Q36018352-91F88B4F-761F-41C4-A362-23C1395A0E1AQ36320084-F2AC911B-EC61-45C2-979F-E2D70D2DD20EQ36334815-DCD36FDD-457F-41B4-A31B-12D98F2E0362Q37519258-82A30E8A-E0A9-415F-96F0-DA88E7B5EA7CQ38288318-44A8C916-6CEA-42CE-8C22-8059F6CB6130Q40277667-57E5F487-EF3C-4A43-82B2-8269192E1D42Q41093329-0043CCD7-917A-47D7-A705-37823F5CD46CQ41498143-C055A946-C0E9-4570-9E46-8EED4189755DQ47106128-51868223-50D8-45C1-A37C-5C0E1BFD80B5Q47200284-DAAC562F-DA99-4FB7-906F-BB80A2685D3CQ47426744-D9B53854-0CEA-4419-A08D-419C79156BEEQ48007055-D7DD12D7-42F2-47C3-BF77-B85C5389B1DAQ48362375-7E24ECE1-A520-45AA-9C56-69B1A642C788Q48526119-981DEB97-4C45-4CE0-A990-6EB81FFC648DQ48559871-C7210C8D-F48F-4545-B028-D779EE7D5C4BQ50071615-80460A84-EBBC-4E51-A6F4-D1D6E79B4A84Q50470371-E1AB1116-DC40-48E6-96F6-E224DCC759AAQ51401379-8C348A4D-E875-4436-B75D-1B0ECC281B7BQ55224160-EB9B27B8-0BC6-47D3-BF34-5B93D52B897AQ57821471-0CF17CCC-5984-413C-B51E-59DBEC8D8D62Q58772957-BD288E0B-ED8E-4BA8-B127-6A46C83FD7B4
P2860
E-cadherin and gastric cancer: cause, consequence, and applications
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
E-cadherin and gastric cancer: cause, consequence, and applications
@ast
E-cadherin and gastric cancer: cause, consequence, and applications
@en
E-cadherin and gastric cancer: cause, consequence, and applications
@nl
type
label
E-cadherin and gastric cancer: cause, consequence, and applications
@ast
E-cadherin and gastric cancer: cause, consequence, and applications
@en
E-cadherin and gastric cancer: cause, consequence, and applications
@nl
prefLabel
E-cadherin and gastric cancer: cause, consequence, and applications
@ast
E-cadherin and gastric cancer: cause, consequence, and applications
@en
E-cadherin and gastric cancer: cause, consequence, and applications
@nl
P2860
P921
P3181
P356
P1476
E-cadherin and gastric cancer: cause, consequence, and applications
@en
P2093
P2860
P304
P3181
P356
10.1155/2014/637308
P407
P50
P5008
P577
2014-08-12T00:00:00Z